Abstract
The pathogenesis of executive dysfunction in geriatric depression remains uncertain although causal bidirectional relationships with depression have been discussed. Previous studies have described a potential link with ‘vascular depression’. In this study, we investigate the influence of vascular risk factors and magnetic resonance imaging markers of structural brain ageing, such as increasing deep white matter hyperintensities (DWMH), on executive function in an age-homogeneous population-based study cohort. A total of 606 participants of identical age (75.8 years; standard deviation 0.45 years) took part in the baseline investigation of the Vienna Transdanube Ageing (VITA) study. Each participant underwent a full psychometric examination with standardised neuroimaging and clinical chemistry investigations. Participants were re-examined with the same protocol after exactly 30 and 60 months. Data refer to the individuals who completed the examination at baseline. In the ordinal logistic regression, fewer years of education (P < 0.0001), Trail Making Test-A (P < 0.0001), high homocysteine (P = 0.001), and depression (P < 0.0001) were significantly associated with Trail Making Test-B (TMT-B) values. A significant influence of other vascular risk factors, such as lipids, diabetes, and smoking, on executive dysfunction was not observed. A comparison of both lacunes and DWMH with respect to the TMT-B results showed no significant correlation. Our data do not support the notion that vascular pathogenesis might underlie executive dysfunction.
Similar content being viewed by others
References
Alexopoulos GS, Meyers BS, Young RC et al (1997) Vascular depression hypothesis. Arch Gen Psychiatry 54:915–922
Allen MD, Owens TE, Fong AK et al (2011) A functional neuroimaging analysis of the Trail Making Test-B: implications for clinical application. Behav Neurol 24:159–171
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
Amieva H, Jacqmin-Gadda H, Orgogozo JM et al (2005) The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 128:1093–1101
Breteler MMB, van Swieten JC, Bots MI et al (1994) Cerebral while matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology 4:1246–1252
Burke WJ, Roccaforte WH, Wengel SP (1991) The short form of the geriatric depression scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol 4:173–178
Cabeza R, Nyberg L (2000) Imaging cognition II: an empirical review of 275 PET and fMRI studies. J Cogn Neurosci 12:1–47
Cummings JL (1993) Frontal-subcortical circuits and human behaviour. Arch Neurol 50:873–880
Debette S, Seshadri S, Beiser A et al (2011) Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77:461–468
De Leeuw FE, de Croot JC, Oudkerk M et al (1999) A follow up study of blood pressure and cerebral white matter lesions. Ann Neurol 46:827–833
Elias MF, Beiser A, Wolf PA et al (2000) The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol 57:808–813
Fassbender K, Mielke O, Bertsch T et al (1999) Homocysteine in cerebral macroangiography and microangiopathy. Lancet 353:1586–1587
Fazekas F, Chawluk JB, Alavi A et al (1987) MR signal abnormalities at 1.5 T in Alzheimer`sdementia and normal aging. AJNR 8:421–427
Fischer P, Jungwirth S, Krampla W et al (2002) Vienna Transdanube Aging ‘VITA’: study design, recruitment strategies and level of participation. J Neural Transm Suppl 62:105–116
Fischer P, Krampla W, Mostafaie N et al (2007) VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly. J Neural Trans Suppl 72:181–188
Fischer P, Zehetmayer S, Bauer K et al (2006) Relation between vascular risk factors and cognition at age 75. Acta Neurol Scand 114:84–90
Frieling H, Röschke B, Kornhuber J et al (2005) Cognitive impairment and its association with homocysteine plasma levels in females with eating disorders-findings from the HEaD-study. J Neural Transm 112:1591–1598
Fukudu H, Kitani M (1995) Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRl. Stroke 26:1593–1597
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Hogervorst E, Ribiero HM, Molyneux A et al (2002) Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 59:787–793
Jack CR Jr, Shiung MM, Weigand SD et al (2005) Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 65:1227–1231
Johnson KJ, Lui LY, Yaffe K (2007) Executive function, more than global cognition, predicts functional decline and mortality in elderly women. J Gerontol A Biol Sci Med Sci 62:1134–1141
Kado D, Selhub J, Seeman T (2001) Plasma total homocysteine levels and cognitive function in older high functioning adults: macarthur studies of successful aging. J Am Geriatr Soc 49:S13
Kalmijn S, Lauer LJ, Lindemans J et al (1999) Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol 150:283–289
Kortte KB, Horner MD, Windham WK (2002) The trail making test, part B: cognitive flexibility or ability to maintain set? Appl Neuropsychol 9:106–109
Krishnan KR, Hays JC, Blazer DG (1997) MRI-defined vascular depression. Am J Psychiatry 154:497–501
Kuller LH, Lopez OL, Newman A et al (2003) Risk factors for dementia in the Cardiovascular Health Cognition Study. Neuroepidemiology 22:13–22
Lena SM, Fiocco AJ, Leyenaar JK (2004) The role of cognitive deficits in the development of eating disorders. Neuropsychol Rev 14:99–113
Liao D, Cooper L, Cai J et al (1996) Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis risk in communities study. Stroke 27:2262–2270
Lindgren A, Roijer A, Rudling O et al (1994) Cerebral lesions on magnetic resonance imaging, heart disease and vascular risk factors in subjects without stroke : a population-based study. Stroke 23:929–934
Longstreth W Jr, Manolio TA, Arnold A et al (1996) Clinical correlates of white matter findings on cranial magnetic resonance aging of 3301 elderly people. The cardiovascular health study. Stroke 27:1274–1282
Misdraji EL, Gass CS (2010) The Trail Making Test and its neurobehavioral components. J Clin Exp Neuropsychol 32:159–163
Munshi MN, Hayes M, Iwata I et al (2012) Education and psychological aspects. Which aspects of executive dysfunction influence ability to manage diabetes in older adults? Diabetes Medicine 29:1171–1177
O’ Brien JT, Erkinjuntti T, Reisberg B et al (2003) Vascular cognitive impairment. Lancet 2:89–98
Pantoni L (2002) Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 13:7–10
Pantoni L, Garcia JH, Gutierrez JA (1996) Cerebral white matter is highly vulnerable to ischemia. Stroke 27:1641–1647
Plassman BL, Williams JW Jr, Burke JR et al (2010) Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 153:182–193
Prins ND, van Dijik EJ, den Heijer T et al (2004) Cerebral white matter lesions and the risk of dementia. Arch Neurol 61:1531–1534
Rainer MK, Mucke HAM, Zehetmayer S et al (2006) Data from the VITA study do not support the concept of vascular depression. Am J Geriatr Psychiatry 14(6):531–537
Reitan R (1956) Trail Making Test. Manual for administration, scoring, and interpretation. Indiana University, Indianapolis
Reutens S, Sachdev P (2002) Homocysteine in neuropsychiatric disorders of the elderly. Int J Geriatr Psychiatry 17:859–864
Riggs KM, Spiro A, Tucker K et al (1996) Relations of vitamin B12, vitamin B6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 63:306–314
Sachdev P (2004) Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 226:25–29
Sanders ML, Lyness JM, Eberly S et al (2006) Cerebrovascular risk factors, executive dysfunction and depression in older primary care patients. Am J Geriatr Psychiatry 14:145–152
Sánchez-Cubillo Periáñez JA, Adrover-Roig D et al (2009) Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc 15:438–450
Schmidt R, Fazekas F, Kapeller P et al (1999) MRI white matter hypertensities—three year follow-up of the Austrian stroke prevention study. Neurology 53:132–139
Schmidt R, Fazekas F, Kleinert G et al (1992) Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter: acomparative study between stroke patients and normal volunteers. Arch Neurol 49:825–827
Seshadri S, Beiser A, Selhub J et al (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer´s disease. N Engl J Med 346:476–483
Stein JH, McBride PE (1998) Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening and treatment. Arch Intern Med 158:1301–1306
Streifler JY, Eliasziw M, Benavente OR et al (2003) Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease. Stroke 34:1913–1916
Stuss DT, Levine B (2002) Adult clinical neuropsychology: lessons from studies of the frontal lobes. Annu Rev Psychol 53:401–433
Thabit H, Kennelly SM, Bhagarva A et al (2009) Utilization of Frontal Assessment Battery and Executive Interview 25 in assessing for dysexecutive syndrome and its association with diabetes self-care in elderly patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 86:208–212
Tombaugh TN (2004) Trail Making Test A and B: normative data stratified by age and education. Achr Clin Neuropsychol 19:203–214
Vazzana R, Bandinelli S, Lauretani F et al (2010) Trail making test predicts physical impairment and mortality in older persons. J Am Geriatr Soc 53:410–415
Vermeer SE, vanDijik EJ, Koudstaal PJ et al (2002) Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam scan study. Ann Neurol 51:285–289
Voos MC, Custódio EB, Malaquias J Jr (2011) Relationship of executive function and educational status with functional balance in older adults. J Geriatr Phys Ther 34(1):11–18
Welch GN, Loscalzo L (1998) Homocysteine and atherosclerosis. N Engl J Med 338:1042–1050
Ylikoski A, Erkinjuntti T, Raininko R et al (1995) WMH on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 86 years living at home. Stroke 26:1171–1177
Zakzanis KK, Mraz R, Graham SJ (2005) An fMRI study of the trail making test. Neuropsychologia 43:1878–1886
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sédille-Mostafaie, N., Zehetmayer, S., Krampla, W. et al. Influence of vascular risk factors on executive function among an age-homogeneous elderly cohort. J Neural Transm 122, 1323–1328 (2015). https://doi.org/10.1007/s00702-015-1389-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-015-1389-1